SINOPHARM GROUP 1/5/O.N. (X2S1) — Working Capital to Net Assets Ratio
SINOPHARM GROUP 1/5/O.N. (X2S1) has a Working Capital to Net Assets ratio of 74.6% as of December 2025. Working capital of €100.07 Billion (current assets of €346.80 Billion minus current liabilities of €246.73 Billion) is measured against net assets of €134.16 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See X2S1 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
SINOPHARM GROUP 1/5/O.N. Working Capital to Net Assets (2021–2025)
This chart shows how SINOPHARM GROUP 1/5/O.N.'s Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 74.6%, reflecting working capital of €100.07 Billion against net assets of €134.16 Billion EUR. For the complete balance sheet picture, see total assets of SINOPHARM GROUP 1/5/O.N..
Annual Working Capital to Net Assets for SINOPHARM GROUP 1/5/O.N. (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for SINOPHARM GROUP 1/5/O.N. from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check SINOPHARM GROUP 1/5/O.N. (X2S1) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 74.6% | €100.07 Billion | €134.16 Billion | €346.80 Billion | €246.73 Billion | ▼ -2.0 pp |
| 2024 | 76.6% | €97.07 Billion | €126.69 Billion | €347.45 Billion | €250.38 Billion | ▼ -2.6 pp |
| 2023 | 79.2% | €95.34 Billion | €120.32 Billion | €336.84 Billion | €241.49 Billion | ▲ +2.5 pp |
| 2022 | 76.7% | €84.44 Billion | €110.07 Billion | €319.41 Billion | €234.96 Billion | ▲ +4.9 pp |
| 2021 | 71.9% | €71.62 Billion | €99.65 Billion | €290.92 Billion | €219.31 Billion | — |